01—Abstract
Summary
Summary of the 8-K filed June 26, 2025. Cited figures are marked; the original filing is the authoritative source.
Labcorp Holdings Inc. (NYSE: LH) furnished this Form 8-K under Item 7.01 (Regulation FD Disclosure) to announce that it will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025.
The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results, and the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The filing is a scheduling announcement and contains no financial results, guidance, or operating metrics.
The accompanying press release (Exhibit 99.1), dated June 26, 2025, describes the call logistics: the webcast will be live and listen-only, participants are advised to join 10 minutes before the start, and a replay will be available approximately two hours after the live event through July 11, 2026. The press release also describes Labcorp as a global laboratory services company with nearly 70,000 employees serving clients in approximately 100 countries, and states that it provided support for more than 75%a of the new drugs and therapeutic products approved in 2024 by the FDA and performs more than 700 million tests annually.
02—Key points
Key Highlights
- Labcorp will report second-quarter 2025 financial results before market open on Thursday, July 24, 2025.
- A conference call and webcast to discuss the results begins at 9 a.m. ET on July 24, 2025.
- The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
- The call is listen-only and webcast live; participants may register via the Investor Relations website for dial-in numbers and a PIN.
- A webcast replay will be available approximately two hours after the live event and until July 11, 2026.
- The filing itself contains no quarterly financial figures; results are to be disclosed in the July 24 release.
- The press release states Labcorp supported more than 75% of new drugs and therapeutic products approved by the FDA in 2024 and performs more than 700 million tests annually.
03—Questions
Frequently Asked Questions
When and how will Labcorp release its second-quarter 2025 results?
Labcorp will release its second-quarter 2025 financial results before the market opens on Thursday, July 24, 2025. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
How can investors participate in the earnings call?
The conference call and webcast begin at 9 a.m. ET on July 24, 2025, and will be webcast live on the Labcorp Investor Relations website. The webcast and dial-in are listen-only. Participants may register through the website to receive dial-in numbers and a unique PIN, and it is recommended they join 10 minutes before the start, though they may join at any time during the call.
Will the call be available for replay?
Yes. A replay will be available approximately two hours after the conclusion of the live event and will remain available until July 11, 2026, through the Labcorp Investor Relations website.
Does this filing disclose Labcorp's second-quarter financial performance?
No. This 8-K is a Regulation FD disclosure announcing the timing and logistics of the earnings release and call. It does not include quarterly revenue, earnings, or guidance figures.
04—Continue